Prof. Laura M. Lechuga is among the scientific coordinators of the 29 units shaping this platform, which allows for development of a therapeutic agent to reach its preclinical validation.
ICN2-sponsored Session Nanodevices for Societal Challenges analysed at TNT 2014 the future of nanotechnology
The Session gathered experts from around Europe in the areas of Biosensors, Theory, ICT and Energy. It was an opportunity to celebrate the Severo Ochoa accreditation in the context of a first-line international event.
Members of ICN2 Nanostructures Functional Materials Group published a series of works developing robust nanoparticles based on coordination polymers for application on theranostics (therapy + diagnosis). They opened a wide variety of possibilities into high added-value medical applications.
Developed by researchers from ICN2 and the UAB, it is the first application using nanoparticles to improve the production of this source of renewable energy and the treatment of organic waste. The technology will be commercialised under the newly created spin-off Applied Nanoparticles.